<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Engrossed-in-Senate" bill-type="olc" dms-id="A1" public-print="no" public-private="public" stage-count="1" star-print="no-star-print"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 S799 ES: Protecting Our Infants Act of 2015</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date></dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form display="yes">
<congress display="yes">114th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">S. 799</legis-num><current-chamber display="no">IN THE SENATE OF THE UNITED STATES</current-chamber><legis-type display="yes">AN ACT</legis-type><official-title display="yes">To address problems related to prenatal opioid use.</official-title></form>
	<legis-body display-enacting-clause="yes-display-enacting-clause" style="OLC">
 <section commented="no" display-inline="no-display-inline" id="id431eb8f3a6044911ad6763f8cdbb2964" section-type="section-one"><enum>1.</enum><header display-inline="yes-display-inline">Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Protecting Our Infants Act of 2015</short-title></quote>.</text> </section><section commented="no" display-inline="no-display-inline" id="idb2a80d60de5e4c02b9e85f8dc97af958" section-type="subsequent-section"><enum>2.</enum><header display-inline="yes-display-inline">Addressing problems related to prenatal opioid use</header> <subsection commented="no" display-inline="no-display-inline" id="idc9315788b6694bdd927c4ac9fd4a6304"><enum>(a)</enum><header display-inline="yes-display-inline">Review of programs</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services (referred to in this Act as the <quote>Secretary</quote>) shall conduct a review of planning and coordination related to prenatal opioid use, including neonatal abstinence syndrome, within the agencies of the Department of Health and Human Services.</text>
 </subsection><subsection commented="no" display-inline="no-display-inline" id="id15ca69336ae0430bbfed25694089ec24"><enum>(b)</enum><header display-inline="yes-display-inline">Strategy</header><text display-inline="yes-display-inline">In carrying out subsection (a), the Secretary shall develop a strategy to address gaps in research and gaps, overlap, and duplication among Federal programs, including those identified in findings made by reports of the Government Accountability Office. Such strategy shall address—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="id3efd3d0fff4a4816952d3c459649094f"><enum>(1)</enum><text display-inline="yes-display-inline">gaps in research, including with respect to—</text> <subparagraph commented="no" display-inline="no-display-inline" id="id5838a22db79a423e85424c736d749cd0"><enum>(A)</enum><text display-inline="yes-display-inline">the most appropriate treatment of pregnant women with opioid use disorders;</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id0a58871a8c574191816b6e37bcec99a9"><enum>(B)</enum><text display-inline="yes-display-inline">the most appropriate treatment and management of infants with neonatal abstinence syndrome; and</text> </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id6dcb1e70b5d7436a928089aec2bf1502"><enum>(C)</enum><text display-inline="yes-display-inline">the long-term effects of prenatal opioid exposure on children;</text>
 </subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="idf4b0e695e03b46769fb5d6f2be8d73e5"><enum>(2)</enum><text display-inline="yes-display-inline">gaps, overlap, or duplication in—</text> <subparagraph commented="no" display-inline="no-display-inline" id="id9134FA10C75B4CCC8B4F24525B0438B2"><enum>(A)</enum><text display-inline="yes-display-inline">substance use disorder treatment programs for pregnant and postpartum women; and</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idE3E466D657EF4DFC8296CF8E3CCB9322"><enum>(B)</enum><text display-inline="yes-display-inline">treatment program options for newborns with neonatal abstinence syndrome;</text> </subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id211ad798161d46c3b9923666ae3e5265"><enum>(3)</enum><text display-inline="yes-display-inline">gaps, overlap, or duplication in Federal efforts related to education about, and prevention of, neonatal abstinence syndrome; and</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="id7bb6c3665d19488e8c65a0d247afa341"><enum>(4)</enum><text display-inline="yes-display-inline">coordination of Federal efforts to address neonatal abstinence syndrome.</text> </paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="idb826ce52eda64cf3b8b371630b4494c9"><enum>(c)</enum><header display-inline="yes-display-inline">Report</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this Act, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report concerning the findings of the review conducted under subsection (a) and the strategy developed under subsection (b).</text>
			</subsection></section><section commented="no" display-inline="no-display-inline" id="idc41b158271a54c02a036859257dddcb1" section-type="subsequent-section"><enum>3.</enum><header display-inline="yes-display-inline">Developing recommendations for preventing and treating prenatal opioid use disorders</header>
 <subsection commented="no" display-inline="no-display-inline" id="id9b01b185b14044658fd60cf4d5960d5c"><enum>(a)</enum><header display-inline="yes-display-inline">In general</header><text display-inline="yes-display-inline">The Secretary shall conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, including the effects of such disorders on infants. In carrying out this subsection the Secretary shall—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="idC5A1AC16B43F45A6A09A0A754AEB26D1"><enum>(1)</enum><text display-inline="yes-display-inline">take into consideration—</text> <subparagraph commented="no" display-inline="no-display-inline" id="id3B0431958ADC42078AF3985A3A134DC2"><enum>(A)</enum><text display-inline="yes-display-inline">the review and strategy conducted and developed under section 2; and</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idAE56930B5DAA4199AAACD132A94AAFF9"><enum>(B)</enum><text display-inline="yes-display-inline">the lessons learned from previous opioid epidemics; and</text> </subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id8A7B9FADDD824C48811C3F84E1BCEEFC"><enum>(2)</enum><text display-inline="yes-display-inline">solicit input from States, localities, and Federally recognized Indian tribes or tribal organizations (as defined in the Indian Self-Determination and Education Assistance Act (<external-xref legal-doc="usc" parsable-cite="usc/25/450b">25 U.S.C. 450b</external-xref>)), and nongovernmental entities, including organizations representing patients, health care providers, hospitals, other treatment facilities, and other entities, as appropriate.</text>
 </paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="idf03906f38fcf41ff81fceb4d1fb76b16"><enum>(b)</enum><header display-inline="yes-display-inline">Report</header><text display-inline="yes-display-inline">Not later than 18 months after the date of enactment of this Act, the Secretary shall make available on the appropriate Internet Website of the Department of Health and Human Services a report on the recommendations under subsection (a). Such report shall address each of the issues described in subsection (c).</text>
 </subsection><subsection commented="no" display-inline="no-display-inline" id="idcbc2461471c4463c9de7f5b9d6d02461"><enum>(c)</enum><header display-inline="yes-display-inline">Contents</header><text display-inline="yes-display-inline">The recommendations described in subsection (a) and the report under subsection (b) shall include—</text> <paragraph commented="no" display-inline="no-display-inline" id="idc97332ab23114e3db5190547b93ff98c"><enum>(1)</enum><text display-inline="yes-display-inline">a comprehensive assessment of existing research with respect to the prevention, identification, treatment, and long-term outcomes of neonatal abstinence syndrome, including the identification and treatment of pregnant women or women who may become pregnant who use opioids or have opioid use disorders;</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="idb781a317add44f2099397d523e49fa1c"><enum>(2)</enum><text display-inline="yes-display-inline">an evaluation of—</text> <subparagraph commented="no" display-inline="no-display-inline" id="id157495dd75704639a0077ef1d483c789"><enum>(A)</enum><text display-inline="yes-display-inline">the causes of, and risk factors for, opioid use disorders among women of reproductive age, including pregnant women;</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id2a641f6366dd4ecbaf33ddd0ce166e31"><enum>(B)</enum><text display-inline="yes-display-inline">the barriers to identifying and treating opioid use disorders among women of reproductive age, including pregnant and postpartum women and women with young children;</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ida27e83252daf4eae952f73a618d9cb1d"><enum>(C)</enum><text display-inline="yes-display-inline">current practices in the health care system to respond to, and treat, pregnant women with opioid use disorders and infants affected by such disorders;</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id84d807d667e542df90c4ec16d5072ec9"><enum>(D)</enum><text display-inline="yes-display-inline">medically indicated uses of opioids during pregnancy;</text> </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id720640c9985b4565bf9472b2e0dfcd6a"><enum>(E)</enum><text display-inline="yes-display-inline">access to treatment for opioid use disorders in pregnant and postpartum women; and</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id1e37f723273742928636154bdca37e34"><enum>(F)</enum><text display-inline="yes-display-inline">access to treatment for infants with neonatal abstinence syndrome; and</text> </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id1E98D714E7864A96ABC989992B9DE1C7"><enum>(G)</enum><text display-inline="yes-display-inline">differences in prenatal opioid use and use disorders in pregnant women between demographic groups; and</text>
 </subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id855041ee47224bc582aa777573323d4e"><enum>(3)</enum><text display-inline="yes-display-inline">recommendations on—</text> <subparagraph commented="no" display-inline="no-display-inline" id="id44f685f0f74e4102b066272b601251d3"><enum>(A)</enum><text display-inline="yes-display-inline">preventing, identifying, and treating the effects of prenatal opioid use on infants;</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id680ee1e4e4674e65a18c83d53ae7e869"><enum>(B)</enum><text display-inline="yes-display-inline">treating pregnant women who have opioid use disorders;</text> </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id5f6aac67d8424bc2a2b930b75280b5f1"><enum>(C)</enum><text display-inline="yes-display-inline">preventing opioid use disorders among women of reproductive age, including pregnant women, who may be at risk of developing opioid use disorders; and</text>
 </subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id46794AE5CFBB4B7488B4F8FAD628F20F"><enum>(D)</enum><text display-inline="yes-display-inline">reducing disparities in opioid use disorders among pregnant women.</text> </subparagraph></paragraph></subsection></section><section commented="no" display-inline="no-display-inline" id="id6ccef9944aed4402bdf2c92d6e24168a" section-type="subsequent-section"><enum>4.</enum><header display-inline="yes-display-inline">Improving data and the public health response</header><text display-inline="no-display-inline">The Secretary may continue activities, as appropriate, related to—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="idcc0f9a7c5c8e4417986b95ff418f9b6f"><enum>(1)</enum><text display-inline="yes-display-inline">providing technical assistance to support States and Federally recognized Indian Tribes in collecting information on neonatal abstinence syndrome through the utilization of existing surveillance systems and collaborating with States and Federally recognized Indian Tribes to improve the quality, consistency, and collection of such data; and</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="id7e530d6de9cd4a08ae41a10610f2c611"><enum>(2)</enum><text display-inline="yes-display-inline">providing technical assistance to support States in implementing effective public health measures, such as disseminating information to educate the public, health care providers, and other stakeholders on prenatal opioid use and neonatal abstinence syndrome.</text></paragraph></section></legis-body><attestation><attestation-group><attestation-date chamber="Senate" date="20151022">Passed the Senate October 22, 2015.</attestation-date><attestor display="no"></attestor><role>Secretary</role></attestation-group></attestation><endorsement display="yes"></endorsement></bill>


